According to the new market research report “European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) – Forecast”, published by MarketsandMarkets™, is projected to reach USD 14 million by 2024 from USD 10 million in 2018, at a CAGR of 5.5% during the forecast period.
Recent Developments:
– In February 2019, Fujifilm (Japan) launched ASPIRE Bellus II.
– In January 2018, Agfa-Gevaert NV (Belgium) signed a contract with the West Suffolk NHS Foundation Trust (UK) in order to implement enterprise imaging for radiology platform.
– In May 2017, Siemens AG (Germany) and Fraunhofer MEVIS (Germany) entered into a partnership for developing artificial intelligence software systems to facilitate diagnosis and therapy decisions in order to support physicians to define the best possible treatment approach.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101392240
The multimodality mammography workstations segment accounted for the largest share of the European mammography workstations market.
On the basis of modality, segmented into mammography (X-ray) workstations and multimodality mammography workstations. In 2018, the multimodality mammography workstations segment accounted for the larger share of the European mammography workstations market. This can be attributed to the increasingly supportive government initiatives/regulations in Europe, increasing awareness about the diagnostic efficacy of contrast-enhanced digital mammography, growing market availability of integrated mammography solutions, techno-commercial advantages associated with multimodality mammography workstations, and the rising prevalence of breast cancer.
The breast care centers segment is expected to register the highest growth rate in the European mammography workstations market.
On the basis of end users, segmented into hospitals, surgical clinics, & diagnostic imaging centers; breast care centers; and researchers & academia. The breast care centers segment is projected to witness the highest growth rate in the mammography workstations market during the forecast period. This can be attributed to the increased utilization of multimodal diagnostic imaging (such as PET-CT, MRI, ultrasound, and mammography) in advanced breast cancer diagnosis, rising number of breast screening programs across major European countries, increasing number of training & awareness programs to sensitize healthcare professionals about the advantages of multimodality mammography workstations, and the growing number of public-private breast care centers across key European countries.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=101392240
Germany dominates the European mammography workstations market
Germany accounted for the largest share of the mammography workstations market in 2018. The large share of Germany is primarily attributed to the better reimbursement scenario in the country as compared to other European countries, wider acceptance of multimodality mammography workstations among major end users (such as hospitals, surgical clinics, and breast care centers), and the rising patient demand for improved cancer screening.
General Electric (US), Siemens (Germany), FUJIFILM Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy) are the major players in the European mammography workstations market.
FUJIFILM is one of the leading players in the European mammography workstations market. The company provides workstations for computed radiography, digital radiography, and digital mammography systems. The company has a strong foothold in Europe. FUJIFILM launched a number of important products in the market in the past three years. The company also focuses on product showcases to increase awareness about its products. For instance, in 2018, the company showcased its advanced image and information systems at the American College of Cardiology’s (ACC) 67th Annual Scientific Session and Expo in Europe. FUJIFILM’S strong brand image and vast geographical coverage are supporting its growth in the market during the forecast period.
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=101392240
